🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
This phase II randomized trial compares the efficacy and safety of Toripali...
Status
Recruiting
Location
Dongguan People's Hospital
Start Date
2026-03-12
Trial ID
NCT07362979
This is a single-arm, multicenter, phase II study to investigate efficacy a...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-08-01
Trial ID
NCT04973904
Treatments Being Tested
The aim of this study is to use the combination of immune checkpoint inhibi...
Status
Completed
Location
Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2020-07-30
Trial ID
NCT04473716
Treatments Being Tested
The aim of this study is to define whether combination of induction chemoth...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-04-07
Trial ID
NCT04995120
Treatments Being Tested
This prospective study aims to investigate whether the time of day when imm...
Status
Recruiting
Location
Hunna Cancer Hospital, Clinical Trails Center
Start Date
2026-08-12
Trial ID
NCT07251582
The combination of surufatinib with neoadjuvant chemo-immunotherapy and def...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2025-07-20
Trial ID
NCT07086469
Treatments Being Tested
The primary objective of this study is to investigate the efficacy and safe...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-03-05
Trial ID
NCT07378306
Treatments Being Tested
The aim of this study is to define whether combination of induction chemoth...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-04-07
Trial ID
NCT05420597
Treatments Being Tested
This is a multicenter, randomized, controlled phase II Study of evaluating ...
Status
Recruiting
Location
Sun yat-sen university cancer center
Start Date
2025-01-01
Trial ID
NCT06904573